NL-OMON22667
Recruiting
Not Applicable
TwinLife: TWIN Longitudinal Investigation of FEtal discordance
The Dutch Heart Foundation0 sites200 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The Dutch Heart Foundation
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •MC twin pregnancies
- •\- Parents aged \= 18 years, who are able to consent
- •\- Written informed consent from both parents to participate in this longitudinal study
Exclusion Criteria
- •\- The presence of major anatomical abnormalities
- •\- Triplet pregnancies or higher order multiple pregnancies
- •\- Twin reversed arterial perfusion (TRAP)
- •\- MC twins with single or double fetal demise
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Study on Effect of Teneligliptin versus Sitagliptin based on ECG changes (Electro Cardiogram for QT interval) in type 2 diabetes mellitus patients.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2018/10/016150Dr Sujoy Ghosh
Active, not recruiting
Phase 1
A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chronic hepatitis B. - NEPTUNEChronic hepatitis BMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2006-000870-63-FRF.Hoffmann-La Roche Ltd524
Active, not recruiting
Not Applicable
A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chronic hepatitis B. - NEPTUNEIn adult patients with HBeAg positive chronic hepatitis B.MedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2006-000870-63-DEF. Hoffmann-La Roche Ltd524
Completed
Not Applicable
Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Submuscular Breast Augmentatio-Z411 Other plastic surgery for unacceptable cosmetic appearanceOther plastic surgery for unacceptable cosmetic appearanceZ411PER-010-07PFIZER S.A.,
Recruiting
Not Applicable
Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the Netherlands * The TWIN studyNL-OMON53107Maag-, Darm- en Leverziekten & Laboratorium voor Translationele Immunologie444